Literature DB >> 16835348

Lack of associations among cancer and albumin adducts, ras p21 oncoprotein levels, and CYP1A1, CYP2D6, NAT1, and NAT2 in a nested case-control study of lung cancer within the physicians' health study.

Frederica P Perera1, Deliang Tang, Paul Brandt-Rauf, Regina M Santella, La Verne A Mooney, Yi-Hsuan Tu, Ivona Bendkowska, Douglas A Bell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16835348      PMCID： PMC1829151          DOI： 10.1158/1055-9965.EPI-05-0691

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  24 in total

Review 1.  Exposure biomarkers for the study of toxicological impact on carcinogenic processes.

Authors:  Peter B Farmer
Journal:  IARC Sci Publ       Date:  2004

Review 2.  Oncogenes and their applications in epidemiologic studies.

Authors:  J A Taylor
Journal:  Am J Epidemiol       Date:  1989-07       Impact factor: 4.897

Review 3.  Oncogenes, growth factors, and signal transduction.

Authors:  B J Druker; H J Mamon; T M Roberts
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

4.  Methodologic considerations in the design and conduct of randomized trials: the U.S. Physicians' Health Study.

Authors:  C H Hennekens; J E Buring
Journal:  Control Clin Trials       Date:  1989-12

Review 5.  Finding the anti-oncogene.

Authors:  R A Weinberg
Journal:  Sci Am       Date:  1988-09       Impact factor: 2.142

6.  Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.

Authors:  S Rodenhuis; M L van de Wetering; W J Mooi; S G Evers; N van Zandwijk; J L Bos
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

Review 7.  Role of genetics and drug metabolism in human cancer risk.

Authors:  D W Nebert
Journal:  Mutat Res       Date:  1991-04       Impact factor: 2.433

8.  Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans.

Authors:  D A Bell; J A Taylor; M A Butler; E A Stephens; J Wiest; L H Brubaker; F F Kadlubar; G W Lucier
Journal:  Carcinogenesis       Date:  1993-08       Impact factor: 4.944

9.  Identification of the primary gene defect at the cytochrome P450 CYP2D locus.

Authors:  A C Gough; J S Miles; N K Spurr; J E Moss; A Gaedigk; M Eichelbaum; C R Wolf
Journal:  Nature       Date:  1990-10-25       Impact factor: 49.962

10.  Polycyclic aromatic hydrocarbon-DNA and protein adducts in coal tar treated patients and controls and their relationship to glutathione S-transferase genotype.

Authors:  R M Santella; F P Perera; T L Young; Y J Zhang; S Chiamprasert; D Tang; L W Wang; A Beachman; J H Lin; V A DeLeo
Journal:  Mutat Res       Date:  1995-04       Impact factor: 2.433
View more
  4 in total

1.  Genetic polymorphisms of CYP2D6 oxidation in patients with systemic sclerosis.

Authors:  Jadwiga Skretkowicz; Malgorzata Baranska; Mariola Rychlik-Sych
Journal:  Eur J Clin Pharmacol       Date:  2009-05-15       Impact factor: 2.953

2.  Adolescent medical providers' willingness to recommend genetic susceptibility testing for nicotine addiction and lung cancer risk to adolescents.

Authors:  Suzanne C O'Neill; George Luta; Beth N Peshkin; Anisha Abraham; Leslie R Walker; Kenneth P Tercyak
Journal:  J Pediatr Psychol       Date:  2008-08-07

3.  NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.

Authors:  Kunyi Zhang; Lijuan Gao; Yuqi Wu; Jianyi Chen; Chengguang Lin; Shaohua Liang; Jianxin Su; Jinming Ye; Xuyu He
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Genetic polymorphisms of CYP2D6 oxidation in patients with systemic lupus erythematosus.

Authors:  Jadwiga Skrętkowicz; Małgorzata Barańska; Anna Kaczorowska; Mariola Rychlik-Sych
Journal:  Arch Med Sci       Date:  2011-11-08       Impact factor: 3.318
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.